Search Results 1001-1010 of 18554 for hepatitis

  1. Study of the EZH2 Inhibitor Tazemetostat in Malignant Mesothelioma - Mayo Clinic

    Has known history of chronic infection with hepatitis B virus (hepatitis B surface antigen positive) or hepatitis C virus (detectable anti-hepatitis C ...

  2. Mayo Clinic Minute: Saving more lives by expanding the donor pool

    Something else that's helping to expand the donor pool is the new generation of antivirals that allow for the safe transplantation of organs from hepatitis C- ...

  3. Cholangiocarcinoma (bile duct cancer) - Doctors and departments - Mayo Clinic

    ... hepatitis, Hepatocellular carcinoma, Hepatopulmonary syndrome, Primary biliary cholangitis, Hepatitis infectious disease, Acute liver failure. Show more ...

  4. Cholangiocarcinoma (bile duct cancer) - Doctors and departments - Mayo Clinic

    ... hepatitis, Hepatocellular carcinoma, Hepatopulmonary syndrome, Primary biliary cholangitis, Hepatitis infectious disease, Acute liver failure. Show more ...

  5. Publications - Membrane Trafficking in Disease - Mayo Clinic Research

    The large GTPase dynamin is required for hepatitis B virus protein secretion from hepatocytes. Journal of Hepatology. 2003; doi:10.1016/s0168-8278(02)00326 ...

  6. Liver Transplant - Overview - Mayo Clinic

    Transplantation in people who are hepatitis C positive; Specialized treatment for obese people who need a liver transplant; Specialized treatment for people ...

  7. A Study to Evaluate the Safety and Effectiveness of IFX-1 in Add-on to Standard of Care in Patients with Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) - Mayo Clinic

    ... hepatitis B, or hepatitis C. One of the following abnormal laboratory findings at Screening: White blood cells < 3500/mm3; Platelet count < 120,000/mm3; Total ...

  8. A Study to Collect Information about Biomarkers (Lab Test Results) that May Help to Predict Which People with Calf Vein Clots May be at Higher or Lower Risk of Having the Clot Grow or Progress - Mayo Clinic

    Significant liver disease (e.g. acute hepatitis, chronic active hepatitis, cirrhosis) or ALT > 3 x ULN. (within last two weeks); Platelet count < 50 x109/L ...

  9. Vancomycin for Primary Sclerosing Cholangitis - Mayo Clinic

    Hepatitis B infection ii. Hepatitis C infection (antibody positive); patients with a history of hepatitis C infection will be eligible for this study if ...

  10. Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma With Excess Glucocorticoid Production - Mayo Clinic

    C virus or hepatitis B virus including: Chronic or active hepatitis B as diagnosed by serologic tests. In equivocal cases, hepatitis B or C polymerase chain ...